222 related articles for article (PubMed ID: 34526722)
21. Differential Cell Susceptibilities to Kras
Shi C; Pan FC; Kim JN; Washington MK; Padmanabhan C; Meyer CT; Kopp JL; Sander M; Gannon M; Beauchamp RD; Wright CV; Means AL
Cell Mol Gastroenterol Hepatol; 2019; 8(4):579-594. PubMed ID: 31310834
[TBL] [Abstract][Full Text] [Related]
22. The Loss of ATRX Increases Susceptibility to Pancreatic Injury and Oncogenic KRAS in Female But Not Male Mice.
Young CC; Baker RM; Howlett CJ; Hryciw T; Herman JE; Higgs D; Gibbons R; Crawford H; Brown A; Pin CL
Cell Mol Gastroenterol Hepatol; 2019; 7(1):93-113. PubMed ID: 30510993
[TBL] [Abstract][Full Text] [Related]
23. Suppression of mutant Kirsten-RAS (KRAS
Kidger AM; Saville MK; Rushworth LK; Davidson J; Stellzig J; Ono M; Kuebelsbeck LA; Janssen KP; Holzmann B; Morton JP; Sansom OJ; Caunt CJ; Keyse SM
Oncogene; 2022 May; 41(20):2811-2823. PubMed ID: 35418690
[TBL] [Abstract][Full Text] [Related]
24. Atypical flat lesions derive from pancreatic acinar cells.
von Figura G; Fahrenkrog-Petersen L; Hidalgo-Sastre A; Hartmann D; Hüser N; Schmid RM; Hebrok M; Roy N; Esposito I
Pancreatology; 2017; 17(3):350-353. PubMed ID: 28473229
[TBL] [Abstract][Full Text] [Related]
25. Lunatic Fringe is a potent tumor suppressor in Kras-initiated pancreatic cancer.
Zhang S; Chung WC; Xu K
Oncogene; 2016 May; 35(19):2485-95. PubMed ID: 26279302
[TBL] [Abstract][Full Text] [Related]
26. Expression of the EWSR1-FLI1 fusion oncogene in pancreas cells drives pancreatic atrophy and lipomatosis.
Fahr L; Sunami Y; Maeritz N; Steiger K; Grünewald TGP; Gericke M; Kong B; Raulefs S; Mayerle J; Michalski CW; Regel I; Kleeff J
Pancreatology; 2020 Dec; 20(8):1673-1681. PubMed ID: 33051146
[TBL] [Abstract][Full Text] [Related]
27. Context-Dependent Epigenetic Regulation of Nuclear Factor of Activated T Cells 1 in Pancreatic Plasticity.
Chen NM; Neesse A; Dyck ML; Steuber B; Koenig AO; Lubeseder-Martellato C; Winter T; Forster T; Bohnenberger H; Kitz J; Reuter-Jessen K; Griesmann H; Gaedcke J; Grade M; Zhang JS; Tsai WC; Siveke J; Schildhaus HU; Ströbel P; Johnsen SA; Ellenrieder V; Hessmann E
Gastroenterology; 2017 May; 152(6):1507-1520.e15. PubMed ID: 28188746
[TBL] [Abstract][Full Text] [Related]
28. Glycogen synthase kinase-3β ablation limits pancreatitis-induced acinar-to-ductal metaplasia.
Ding L; Liou GY; Schmitt DM; Storz P; Zhang JS; Billadeau DD
J Pathol; 2017 Sep; 243(1):65-77. PubMed ID: 28639695
[TBL] [Abstract][Full Text] [Related]
29. KRAS2 mutations in human pancreatic acinar-ductal metaplastic lesions are limited to those with PanIN: implications for the human pancreatic cancer cell of origin.
Shi C; Hong SM; Lim P; Kamiyama H; Khan M; Anders RA; Goggins M; Hruban RH; Eshleman JR
Mol Cancer Res; 2009 Feb; 7(2):230-6. PubMed ID: 19208745
[TBL] [Abstract][Full Text] [Related]
30. Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice.
Habbe N; Shi G; Meguid RA; Fendrich V; Esni F; Chen H; Feldmann G; Stoffers DA; Konieczny SF; Leach SD; Maitra A
Proc Natl Acad Sci U S A; 2008 Dec; 105(48):18913-8. PubMed ID: 19028870
[TBL] [Abstract][Full Text] [Related]
31. A novel pancreatic cancer model originated from transformation of acinar cells in adult tree shrew, a primate-like animal.
Tu Q; Yang D; Zhang X; Jia X; An S; Yan L; Dai H; Ma Y; Tang C; Tong W; Hou Z; Lv L; Tan J; Zhao X
Dis Model Mech; 2019 Apr; 12(4):. PubMed ID: 30910991
[TBL] [Abstract][Full Text] [Related]
32. Prox1-Heterozygosis Sensitizes the Pancreas to Oncogenic Kras-Induced Neoplastic Transformation.
Drosos Y; Neale G; Ye J; Paul L; Kuliyev E; Maitra A; Means AL; Washington MK; Rehg J; Finkelstein DB; Sosa-Pineda B
Neoplasia; 2016 Mar; 18(3):172-84. PubMed ID: 26992918
[TBL] [Abstract][Full Text] [Related]
33. Early requirement of Rac1 in a mouse model of pancreatic cancer.
Heid I; Lubeseder-Martellato C; Sipos B; Mazur PK; Lesina M; Schmid RM; Siveke JT
Gastroenterology; 2011 Aug; 141(2):719-30, 730.e1-7. PubMed ID: 21684285
[TBL] [Abstract][Full Text] [Related]
34. Reconstitution of human PDAC using primary cells reveals oncogenic transcriptomic features at tumor onset.
Xu Y; Nipper MH; Dominguez AA; Ye Z; Akanuma N; Lopez K; Deng JJ; Arenas D; Sanchez A; Sharkey FE; Court CM; Singhi AD; Wang H; Fernandez-Zapico ME; Sun LZ; Zheng S; Chen Y; Liu J; Wang P
Nat Commun; 2024 Jan; 15(1):818. PubMed ID: 38280869
[TBL] [Abstract][Full Text] [Related]
35. A human cancer xenograft model utilizing normal pancreatic duct epithelial cells conditionally transformed with defined oncogenes.
Inagawa Y; Yamada K; Yugawa T; Ohno S; Hiraoka N; Esaki M; Shibata T; Aoki K; Saya H; Kiyono T
Carcinogenesis; 2014 Aug; 35(8):1840-6. PubMed ID: 24858378
[TBL] [Abstract][Full Text] [Related]
36. A genetically engineered mouse model developing rapid progressive pancreatic ductal adenocarcinoma.
Yamaguchi T; Ikehara S; Nakanishi H; Ikehara Y
J Pathol; 2014 Oct; 234(2):228-38. PubMed ID: 25042889
[TBL] [Abstract][Full Text] [Related]
37. KLF4 Is Essential for Induction of Cellular Identity Change and Acinar-to-Ductal Reprogramming during Early Pancreatic Carcinogenesis.
Wei D; Wang L; Yan Y; Jia Z; Gagea M; Li Z; Zuo X; Kong X; Huang S; Xie K
Cancer Cell; 2016 Mar; 29(3):324-338. PubMed ID: 26977883
[TBL] [Abstract][Full Text] [Related]
38. Serotonin uptake is required for Rac1 activation in Kras-induced acinar-to-ductal metaplasia in the pancreas.
Saponara E; Visentin M; Baschieri F; Seleznik G; Martinelli P; Esposito I; Buschmann J; Chen R; Parrotta R; Borgeaud N; Bombardo M; Malagola E; Caflisch A; Farhan H; Graf R; Sonda S
J Pathol; 2018 Nov; 246(3):352-365. PubMed ID: 30058725
[TBL] [Abstract][Full Text] [Related]
39. Loss of Setd2 promotes Kras-induced acinar-to-ductal metaplasia and epithelia-mesenchymal transition during pancreatic carcinogenesis.
Niu N; Lu P; Yang Y; He R; Zhang L; Shi J; Wu J; Yang M; Zhang ZG; Wang LW; Gao WQ; Habtezion A; Xiao GG; Sun Y; Li L; Xue J
Gut; 2020 Apr; 69(4):715-726. PubMed ID: 31300513
[TBL] [Abstract][Full Text] [Related]
40. KRAS mutation and epithelial-macrophage interplay in pancreatic neoplastic transformation.
Bishehsari F; Zhang L; Barlass U; Preite NZ; Turturro S; Najor MS; Shetuni BB; Zayas JP; Mahdavinia M; Abukhdeir AM; Keshavarzian A
Int J Cancer; 2018 Oct; 143(8):1994-2007. PubMed ID: 29756386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
